Literature DB >> 3818128

Tumor type-specific differences in cell-substrate adhesion among human tumor cell lines.

J Varani, T E Carey, S E Fligiel, P E McKeever, V Dixit.   

Abstract

Cell lines derived from human tumors of 4 different histological types (squamous carcinomas, melanomas, gliomas and a fibrosarcoma) were examined for cell-substrate adhesion on plastic culture dishes and dishes coated with 50 micrograms of type-IV collagen. In the absence of exogenous adhesion factors, the squamous carcinoma cells attached and spread more rapidly than the other cells on both substrates. Once attached, the squamous carcinoma cells were also more difficult than the other cells to remove with proteolytic enzymes/EDTA. While the cell lines derived from melanomas, gliomas and the fibrosarcoma were less adhesive than the squamous carcinoma lines in the absence of exogenous adhesion factors, these cells were highly responsive to laminin. In contrast, laminin only slightly enhanced the attachment and spreading of squamous carcinoma cells on the plastic dishes and actually inhibited attachment and spreading on the collagen-coated dishes. These results indicate that there are tumor-type-specific differences in adhesiveness among human tumor cell lines and that cells from different tumor types may have distinct mechanisms for carrying out one of the functions critical to invasion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3818128     DOI: 10.1002/ijc.2910390321

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Effects of laminin on the attachment of glioma cells to type IV collagen.

Authors:  G Hunt; G V Sherbet
Journal:  Clin Exp Metastasis       Date:  1989 May-Jun       Impact factor: 5.150

2.  Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas.

Authors:  M Streit; P Velasco; L F Brown; M Skobe; L Richard; L Riccardi; J Lawler; M Detmar
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

3.  Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma.

Authors:  V Castle; J Varani; S Fligiel; E V Prochownik; V Dixit
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

4.  Thrombospondin 1 synthesis and function in wound repair.

Authors:  L A DiPietro; N N Nissen; R L Gamelli; A E Koch; J M Pyle; P J Polverini
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

5.  Substrate adhesiveness and experimental metastatic potential of rat ascites hepatoma AH7974-derived variant sublines.

Authors:  T Kawaguchi; S Igarashi; H Wakabayashi; S Yokoya; K Fukui
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

6.  The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay.

Authors:  M E Berens; M D Rief; M A Loo; A Giese
Journal:  Clin Exp Metastasis       Date:  1994-11       Impact factor: 5.150

Review 7.  Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

8.  Modulation of fibronectin production in normal human melanocytes and malignant melanoma cells by interferon-gamma and tumor necrosis factor-alpha.

Authors:  J Varani; R S Mitra; B J McClenic; S E Fligiel; D R Inman; V M Dixit; B J Nickoloff
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

9.  Thrombospondin-induced adhesion of human keratinocytes.

Authors:  J Varani; B J Nickoloff; B L Riser; R S Mitra; K O'Rourke; V M Dixit
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

10.  Characterization of thrombospondin synthesis, secretion and cell surface expression by human tumor cells.

Authors:  J Varani; B L Riser; L A Hughes; T E Carey; S E Fligiel; V M Dixit
Journal:  Clin Exp Metastasis       Date:  1989 May-Jun       Impact factor: 5.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.